Literature DB >> 21195071

Müllerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons.

Andrew N Clarkson1, Caroline L Talbot, Pei-Yu Wang, David T MacLaughlin, Patricia K Donahoe, Ian S McLennan.   

Abstract

Müllerian Inhibiting Substance (MIS, Anti-Müllerian hormone) is a gonadal hormone that contributes to the subtle sex-biases in the nervous system. Mature neurons of both sexes also produce MIS, suggesting that MIS may be a paracrine regulator of adult neural networks. We report here that murine hypoglossal motor neurons produce MIS and its receptors, MISRII and bone morphogenetic protein receptor 1A (BMPR1A, ALK3), but differentially transport them, with only MIS being detectable in axons. The production of MIS and its receptors were rapidly down regulated after axonal damage, which is a characteristic of genes involved in mature neuronal function. MIS is a survival factor for embryonic spinal motor neurons, but the rate of cell loss after hypoglossal nerve avulsion was normal in Mis(-/-) mice and was not attenuated by intraventricular administration of MIS. These observations suggest that MIS may be involved in anterograde rather than autocrine or retrograde regulation of neurons.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195071      PMCID: PMC3797533          DOI: 10.1016/j.expneurol.2010.12.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  28 in total

Review 1.  Sex determination and differentiation.

Authors:  David T MacLaughlin; Patricia K Donahoe
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

Review 2.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 3.  Progressive muscular atrophy and other lower motor neuron syndromes of adults.

Authors:  Lewis P Rowland
Journal:  Muscle Nerve       Date:  2010-02       Impact factor: 3.217

4.  Antimüllerian hormone serum levels: a putative marker for ovarian aging.

Authors:  Annemarie de Vet; Joop S E Laven; Frank H de Jong; Axel P N Themmen; Bart C J M Fauser
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

5.  Interleukin-6 (IL6) and cellular response to facial nerve injury: effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice.

Authors:  M Galiano; Z Q Liu; R Kalla; M Bohatschek; A Koppius; A Gschwendtner; S Xu; A Werner; C U Kloss; L L Jones; H Bluethmann; G Raivich
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

6.  Mullerian inhibiting substance acts as a motor neuron survival factor in vitro.

Authors:  Pei-Yu Wang; Kyoko Koishi; Andrew B McGeachie; Michael Kimber; David T Maclaughlin; Patricia K Donahoe; Ian S McLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

7.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Authors:  Diether Lambrechts; Erik Storkebaum; Masafumi Morimoto; Jurgen Del-Favero; Frederik Desmet; Stefan L Marklund; Sabine Wyns; Vincent Thijs; Jörgen Andersson; Ingrid van Marion; Ammar Al-Chalabi; Stephanie Bornes; Rhiannon Musson; Valerie Hansen; Lars Beckman; Rolf Adolfsson; Hardev Singh Pall; Hervé Prats; Severine Vermeire; Paul Rutgeerts; Shigehiro Katayama; Takuya Awata; Nigel Leigh; Loïc Lang-Lazdunski; Mieke Dewerchin; Christopher Shaw; Lieve Moons; Robert Vlietinck; Karen E Morrison; Wim Robberecht; Christine Van Broeckhoven; Désiré Collen; Peter M Andersen; Peter Carmeliet
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

8.  The neurotrophic effects of glial cell line-derived neurotrophic factor on spinal motoneurons are restricted to fusimotor subtypes.

Authors:  Thomas W Gould; Shigenobu Yonemura; Ronald W Oppenheim; Shiho Ohmori; Hideki Enomoto
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

9.  Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

Authors:  M M Lee; P K Donahoe; T Hasegawa; B Silverman; G B Crist; S Best; Y Hasegawa; R A Noto; D Schoenfeld; D T MacLaughlin
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

10.  Müllerian-inhibiting substance function during mammalian sexual development.

Authors:  R R Behringer; M J Finegold; R L Cate
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

View more
  5 in total

1.  Circulating anti-Müllerian hormone (AMH) associates with the maturity of boys' drawings: Does AMH slow cognitive development in males?

Authors:  Kirstie Morgan; Ted Ruffman; David K Bilkey; Ian S McLennan
Journal:  Endocrine       Date:  2017-06-07       Impact factor: 3.633

2.  AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.

Authors:  David Pépin; Amanda Sosulski; Lihua Zhang; Dan Wang; Vinod Vathipadiekal; Katherine Hendren; Caroline M Coletti; Aaron Yu; Cesar M Castro; Michael J Birrer; Guangping Gao; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

Review 3.  Gene delivery to the hypoglossal motor system: preclinical studies and translational potential.

Authors:  Brendan M Doyle; Michele L Singer; Thomaz Fleury-Curado; Sabhya Rana; Ethan S Benevides; Barry J Byrne; Vsevolod Y Polotsky; David D Fuller
Journal:  Gene Ther       Date:  2021-02-11       Impact factor: 5.250

4.  Regulation of Murine Ovarian Epithelial Carcinoma by Vaccination against the Cytoplasmic Domain of Anti-Müllerian Hormone Receptor II.

Authors:  Cagri Sakalar; Suparna Mazumder; Justin M Johnson; Cengiz Z Altuntas; Ritika Jaini; Robert Aguilar; Sathyamangla V Naga Prasad; Denise C Connolly; Vincent K Tuohy
Journal:  J Immunol Res       Date:  2015-11-05       Impact factor: 4.818

5.  AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice.

Authors:  Brendan M Doyle; Sara M F Turner; Michael D Sunshine; Phillip A Doerfler; Amy E Poirier; Lauren A Vaught; Marda L Jorgensen; Darin J Falk; Barry J Byrne; David D Fuller
Journal:  Mol Ther Methods Clin Dev       Date:  2019-08-31       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.